Rosiglitazone Improves Insulin Resistance, Lipid Profile and Promotes Adiposity in a Genetic Model of Metabolic Syndrome X Cited by

Fol. Biol. 2002, 48, 237-241

https://doi.org/10.14712/fb2002048060237

Rosiglitazone Improves Insulin Resistance, Lipid Profile and Promotes Adiposity in a Genetic Model of Metabolic Syndrome X

O. Šeda^1,2, L. Kazdová¹, D. Křenová², Vladimír Křen^2,3

¹Institute for Clinical and Experimental Medicine, Prague, Czech Republic
²Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
³Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Received September 2002
Accepted October 2002

Crossref Cited-by Linking

SALEH SAMIRA, EL-MARAGHY NABILA, REDA ENJI, BARAKAT WALEED: Modulation of Diabetes and Dyslipidemia in Diabetic Insulin-Resistant Rats by Mangiferin: Role of Adiponectin and TNF-\u03b1. An. Acad. Bras. Ciênc. 2014, 86, 1935. <https://doi.org/10.1590/0001-3765201420140212>
Printz Morton P., Jirout Martin, Jaworski Rebecca, Alemayehu Adamu, Kren Vladimir: Invited Review: HXB/BXH rat recombinant inbred strain platform: a newly enhanced tool for cardiovascular, behavioral, and developmental genetics and genomics. Journal of Applied Physiology 2003, 94, 2510. <https://doi.org/10.1152/japplphysiol.00064.2003>